Ben Sidders on integrating causality in AI for R&D success

Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.

Maximising value by uniting the digital backbone: On a new N...

Novo Nordisk and Veeva have entered into a new partnership for clinical development.

Precision, speed, impact: Evolving mass spectrometry for med...

MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.

Where innovation meets collaboration: Live from Manchester’s...

Bringing patients to research centres: Using AI to bring eff...

Driving the drug discovery pipeline: The value of organ-on-a...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.